Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (3): 262-265.doi: 10.35541/cjd.20220659
• Special Article • Previous Articles Next Articles
Wang Xingwang, Yang Huilan
Received:
2022-09-16
Revised:
2022-12-30
Online:
2023-03-15
Published:
2023-03-06
Contact:
Yang Huilan
E-mail:huilany88@vip.163.com
Wang Xingwang, Yang Huilan. Reasonable selection of antiviral agents for herpes zoster[J]. Chinese Journal of Dermatology, 2023, 56(3): 262-265.doi:10.35541/cjd.20220659
[1] | Le P, Rothberg M. Herpes zoster infection[J]. BMJ, 2019,364:k5095. doi: 10.1136/bmj.k5095. |
[2] | Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia[J]. Cochrane Database Syst Rev, 2014,(2):CD006866. doi: 10.1002/14651858.CD006866.pub3. |
[3] | 郝飞. 重视带状疱疹早期规范化抗病毒治疗[J]. 中华医学信息导报, 2021,36(15):17. doi: 10.3760/cma.j.issn.1000⁃8039. 2021.15.133. |
[4] | 中国医师协会皮肤科医师分会带状疱疹专家共识工作组 国 家皮肤与免疫疾病临床医学研究中心. 中国带状疱疹诊疗 专家共识(2022版)[J]. 中华皮肤科杂志, 2022,55(12):1033⁃ 1040. doi:10.35541/cjd.20220608. |
[5] | Kennedy P, Gershon AA. Clinical features of varicella⁃zoster virus infection[J]. Viruses, 2018,10(11):609. doi: 10.3390/v10110609. |
[6] | Cohen JI. Clinical practice: herpes zoster[J]. N Engl J Med, 2013,369(3):255⁃263. doi: 10.1056/NEJMcp1302674. |
[7] | 杨慧兰. 带状疱疹中国专家共识解读[J]. 中华皮肤科杂志, 2018,51(9):699⁃701. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 09.021. |
[8] | Werner RN, Nikkels AF, Marinović B, et al. European consensus⁃based (S2k) guideline on the management of herpes zoster ⁃ guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment[J]. J Eur Acad Dermatol Venereol, 2017,31(1):20⁃29. doi: 10.1111/jdv.13957. |
[9] | Gross GE, Eisert L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia[J]. J Dtsch Dermatol Ges, 2020,18(1):55⁃78. doi: 10.1111/ddg.14013. |
[10] | Gross G, Schöfer H, Wassilew S, et al. Herpes zoster guideline of the German Dermatology Society (DDG)[J]. J Clin Virol, 2003,26(3):277⁃289; discussion 291⁃293. doi: 10.1016/s1386⁃6532(03)00005⁃2. |
[11] | Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster[J]. Clin Infect Dis, 2007,44 Suppl 1:S1⁃S26. doi: 10.1086/510206. |
[12] | Andrei G, Snoeck R. Advances and perspectives in the management of varicella⁃zoster virus infections[J]. Molecules, 2021,26(4):1132. doi: 10.3390/molecules26041132. |
[13] | de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration[J]. J Antimicrob Chemother, 1983,12 Suppl B:29⁃37. doi: 10.1093/jac/12.suppl_b.29. |
[14] | Field HJ, Vere Hodge RA. Recent developments in anti⁃herpesvirus drugs[J]. Br Med Bull, 2013,106:213⁃249. doi: 10. 1093/bmb/ldt011. |
[15] | Pergam SA, Limaye AP, AST Infectious Diseases Community of Practice. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019,33(9):e13622. doi: 10.1111/ctr.13622. |
[16] | Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2008,47(3):303⁃327. doi: 10.1086/589747. |
[17] | Perry CM, Faulds D. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections[J]. Drugs, 1996,52(5):754⁃772. doi: 10. 2165/00003495⁃199652050⁃00009. |
[18] | Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults[J]. Antimicrob Agents Chemother, 1995,39(7):1546⁃1553. doi: 10.1128/AAC.39.7.1546. |
[19] | Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro⁃drug valaciclovir after escalating single⁃ and multiple⁃dose administration to normal volunteers[J]. Clin Pharmacol Ther, 1993,54(6):595⁃605. doi: 10.1038/clpt.1993. 196. |
[20] | Lin WR, Lin HH, Lee SS, et al. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster[J]. J Microbiol Immunol Infect, 2001,34(2):138⁃142. |
[21] | Yao H, Zhu C, Liu L, et al. Different dosages of valaciclovir for the treatment of herpes zoster in adults: a randomized clinical study[J]. J Clin Pharm Ther, 2021,46(3):717⁃723. doi: 10. 1111/jcpt.13336. |
[22] | 周村建, 王莉, 郭在培, 等. 不同剂量和疗程伐昔洛韦治疗带状疱疹的多中心随机双盲对照研究[J]. 临床皮肤科杂志, 2007,36(7):420⁃422. doi: 10.3969/j.issn.1000⁃4963.2007.07. 004. |
[23] | Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment[J]. Korean J Pain, 2015,28(3):177⁃184. doi: 10.3344/kjp.2015.28.3.177. |
[24] | Pott Junior H, de Oliveira M, Gambero S, et al. Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults[J]. Int J Infect Dis, 2018,72:11⁃15. doi: 10.1016/j.ijid.2018.04.4324. |
[25] | Oka T, Hishizawa M, Yamashita K, et al. Successful treatment with famciclovir for varicella zoster virus infection resistant to acyclovir[J]. J Infect Chemother, 2021,27(5):755⁃758. doi: 10.1016/j.jiac.2020.12.013. |
[26] | Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management[J]. Viruses, 2022,14(2):192. doi: 10.3390/v14020192. |
[27] | 王爱平, 王军, 李若瑜. 抗病毒药物溴夫定[J]. 中华皮肤科杂志, 2010,43(8):595⁃597. |
[28] | Wassilew SW, Wutzler P, Brivddin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double⁃blind, multicentered study[J]. Antiviral Res, 2003,59(1):49⁃56. doi: 10.1016/s0166⁃3542(03)00065⁃2. |
[29] | De Clercq E. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster[J]. Biochem Pharmacol, 2004,68(12):2301⁃2315. doi: 10.1016/j.bcp.2004.07. 039. |
[30] | Diasio RB. Sorivudine and 5⁃fluorouracil; a clinically significant drug⁃drug interaction due to inhibition of dihydropyrimidine dehydrogenase[J]. Br J Clin Pharmacol, 1998,46(1):1⁃4. doi: 10.1046/j.1365⁃2125.1998.00050.x. |
[31] | Duda JF, Castro JG. Bilateral retrobulbar optic neuritis caused by varicella zoster virus in a patient with AIDS[J]. Br J Med Med Res, 2015,5(11):1381⁃1386. doi: 10.9734/BJMMR/2015/14259. |
[32] | Sauerbrei A, Taut J, Zell R, et al. Resistance testing of clinical varicella⁃zoster virus strains[J]. Antiviral Res, 2011,90(3):242⁃247. doi: 10.1016/j.antiviral.2011.04.005. |
[33] | Piret J, Boivin G. Antiviral resistance in herpes simplex virus and varicella⁃zoster virus infections: diagnosis and management[J]. Curr Opin Infect Dis, 2016,29(6):654⁃662. doi: 10.1097/QCO.0000000000000288. |
[1] | Zheng Jingbing, Han Huimin, Wang Shan, Sun Qian. Changes in CD100 expression and its regulation on CD8+ T cell function in peripheral blood of patients with herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(3): 234-240. |
[2] | Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104. |
[3] | Consensus Workgroup on Herpes Zoster, China Dermatologist Association, National Clinical Research Center for Skin and Immune Diseases. Chinese consensus on the diagnosis and management of herpes zoster (2022) [J]. Chinese Journal of Dermatology, 2022, 55(12): 1033-1040. |
[4] | Liang Yanhua, Yang Yao, Mo Huihui. Detection of varicella-zoster virus in different specimens from patients with acute herpes zoster [J]. Chinese Journal of Dermatology, 2022, 55(10): 889-891. |
[5] | Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 55(10): 881-884. |
[6] | Yang Jingjing, Zhao Yang, Fan Jianyong, Yang Huilan. Correlation between interferon-γ rs2430561 single nucleotide polymorphisms and susceptibility to herpes zoster [J]. Chinese Journal of Dermatology, 2021, 54(6): 510-513. |
[7] | Wang Miaomiao, Yang Ziliang, Zhou Naihui, Song Linyi, Min Wei, Liu Ming, Qian Qihong, Feng Xuemei, Li Min, Lu Yifeng. Wolf′s isotopic response manifesting as granulomatous inflammation after disseminated herpes zoster: a case report [J]. Chinese Journal of Dermatology, 2021, 54(10): 887-890. |
[8] | Expert Group on Ability Improvement Project for Chronic Dermatological Diseases, Chinese Medical Association Publishing House, Pain Physician Branch of Chinese Medical Doctor Association, Dermatology Committee, National Telemedicine and Connected Health Center. Expert consensus on the whole-process management of herpes zoster-associated pain [J]. Chinese Journal of Dermatology, 2021, 54(10): 841-846. |
[9] | Zhao Yang, Tian Chen, Yang Jingjing, Fan Jianyong, Yang Huilan. Detection of autophagy in peripheral CD4+ T lymphocytes and skin lesions of patients with herpes zoster [J]. Chinese Journal of Dermatology, 2020, 53(1): 30-35. |
[10] | . Therapeutic effect of combined glucocorticoids on herpes zoster of the head and face in the elderly [J]. Chinese Journal of Dermatology, 2018, 51(9): 670-672. |
[11] | . Two cases of acquired immunodeficiency syndrome with skin eruptions as the first symptom [J]. Chinese Journal of Dermatology, 2012, 45(1): 56-56. |
[12] | . Brivudine:an antiviral agent [J]. Chinese Journal of Dermatology, 2010, 43(8): 595-597. |
[13] | ZHENG Bo, ZHONG Ming-ying, ZHANG Jin-ping, WANG Qian-qiu. In vitro antiviral susceptibilities of HSV-2 clinical isolates to acyclovir and valaciclovir [J]. Chinese Journal of Dermatology, 2007, 40(3): 143-145. |
[14] | WANG Ai-ping, QI Jun, WANG Hong-wei, ZHAO Qing-li, ZHU Wei, YU Jin, ZHAO Hua, LI Hong-chun, LIU Wen, ZHAO Chen, WANG Ke, LI Heng-jin, WANG Bao-xi, ZHAO Guang, LIAN Shi, ZHU Xue-jun. Evaluation of efficacy and safety of brivudine once daily versus 4 times daily in the treatment of herpes zoster [J]. Chinese Journal of Dermatology, 2007, 40(12): 717-719. |
[15] | Zheng Jiarun, Tang Meiyu, Yu Yanhua. Study on Anti Herpes Simplex Virus Activity of Dipyridamole in Vitro [J]. Chinese Journal of Dermatology, 1998, 31(4): 230-232. |
|